Product Information
IBUPROFEN 100 MG/5 ML SUSP is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0243 per ML under NDC 59651003247. Its NADAC has been published 389 times since Mar 13, 2019.
FDA first approved this application on Feb 16, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
100 mg/5mL
Manufacturer
Aurobindo Pharma LimitedNDC
59651003247
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
IBUPROFENApproval Type
Generic (ANDA)
FDA Application
ANDA209178FDA Approved
2/16/2018
TE Code
AB
On Market Since
2/16/2018
Pharmacological Classes
Price Statistics
The NADAC for IBUPROFEN 100 MG/5 ML SUSP has been published 389 times since Mar 13, 2019, and over the history we have for it it has declined 32.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0243 per ML |
|---|---|
| All-time high | $0.0419 (Feb 12, 2020) |
| All-time low | $0.0185 (Nov 20, 2024) |
| 52-week high | $0.0256 |
| 52-week low | $0.0236 |
| Median price | $0.0280 |
| Average price | $0.0293 |
| Largest weekly change | +33.6% (May 18, 2022) |
| Weeks tracked | 389 |
| Tracking since | Mar 13, 2019 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of IBUPROFEN 100 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for IBUPROFEN 100 MG/5 ML SUSP, manufactured by Aurobindo Pharma Limited, is $0.0243 per ML (NDC 59651003247), effective Aug 19, 2026.
How has the price of IBUPROFEN 100 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for IBUPROFEN 100 MG/5 ML SUSP has declined 32.0%. It has been tracked across 389 weekly CMS publications since Mar 13, 2019.
What are the highest and lowest recorded NADAC prices for IBUPROFEN 100 MG/5 ML SUSP?
Since Mar 13, 2019, the NADAC for IBUPROFEN 100 MG/5 ML SUSP has ranged from a low of $0.0185 (Nov 20, 2024) to a high of $0.0419 (Feb 12, 2020), with a median of $0.0280 per ML.
Are there cheaper alternatives to IBUPROFEN 100 MG/5 ML SUSP?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as IBUPROFEN 100 MG/5 ML SUSP in a comparable dosage form, but none are currently priced below it.
Who manufactures IBUPROFEN 100 MG/5 ML SUSP?
IBUPROFEN 100 MG/5 ML SUSP (NDC 59651003247) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.